Kamath et al. [127] reported a redox-responsive LNP loaded with TP53-coding mRNA, and studied the therapeutic effects of this LNP in TP53-deficient Hep3B HCC and H1299 NSCLC cells. Here, TP53 is linked to non-small cell lung carcinoma.